PharmaCorp Rx

PharmaCorp Rx Liabilities

The The Liabilities of PharmaCorp Rx (PCRX.V) as of Oct 21, 2026 is 13.30 M CAD. In the previous year, The Liabilities was 4.64 M CAD — a change of 186.47% (higher).

Liabilities

13.30 MCAD

YoY

186.47%

Last updated:

In 2025, PharmaCorp Rx's total liabilities amounted to 13.30 M CAD, a 186.47% difference from the 4.64 M CAD total liabilities in the previous year.

The PharmaCorp Rx Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2021
26,343.00 CAD
Jan 1, 2022
16,465.00 CAD
Jan 1, 2023
46,185.00 CAD
Jan 1, 2024
4.64 M CAD
Jan 1, 2025
13.30 M CAD
The PharmaCorp Rx Liabilities history
YEARLiabilitiesYoY
13.30 MCAD+186.47%
4.64 MCAD+9,952.57%
46,185.00CAD+180.50%
16,465.00CAD-37.50%
26,343.00CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

PharmaCorp Rx Stock analysis

What does PharmaCorp Rx do? PharmaCorp Rx is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing PharmaCorp Rx's Liabilities

PharmaCorp Rx's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating PharmaCorp Rx's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing PharmaCorp Rx's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

PharmaCorp Rx's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in PharmaCorp Rx’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about PharmaCorp Rx stock

The Liabilities of PharmaCorp Rx is 13.30 M CAD in 2025.

The Liabilities of PharmaCorp Rx changed from 4.64 M CAD to 13.30 M CAD, representing a 186.47% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities PharmaCorp Rx since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's CAD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's PharmaCorp Rx historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — PharmaCorp Rx

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — PharmaCorp Rx